Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin C

What does the research say about Vitamin C?

9 health outcomes synthesised

Research on Vitamin C spans 9 health outcomes, encompassing inflammation, blood pressure, pain, and critical illness. The strongest evidence supports vitamin C for reducing interleukin-6 levels and complex regional pain syndrome, with moderate-strength findings from 5 and 3 studies, respectively. Doses around 1000 mg/day are commonly used in clinical populations, such as cardiac surgery and knee arthroplasty patients.

Strongest evidence: Two outcomes carry moderate evidence strength. For reducing interleukin-6 levels, 3 of 5 studies reported beneficial moderate-to-large effects in clinical populations (cardiac surgery, septic shock, hemodialysis) at doses around 1000 mg/day over 42 days. For reducing complex regional pain syndrome, all 3 studies found small but statistically significant benefits in total knee arthroplasty patients using 1 g daily for about 40 days. A third moderate-strength outcome—reducing systolic blood pressure—showed moderate reductions (~3.7 mmHg) in 3 studies, primarily in adults with type 2 diabetes, though dosing was inconsistently reported.

Mixed or weaker evidence: Outcomes with low evidence strength show more uncertainty. For reduced mortality risk, only 1 of 5 studies reported a benefit (in COVID-19 patients), with 4 neutral findings in sepsis populations over short durations (median 4 days). For reduced tumor necrosis factor alpha, 2 of 4 studies showed moderate effects at 250–1000 mg/day over 56 days, but 2 were neutral. Improved lung function had mixed results: 2 of 4 studies were beneficial (one statistically significant in children of pregnant smokers at 500 mg/day), while meta-analyses in asthma and COPD found no effect. Reduced pain showed moderate effects in 3 of 4 surgical studies, but one observational study was neutral. Reduced oxidative stress had 3 of 4 studies beneficial at 1000 mg/day over 12 weeks, but the evidence base is small. Reduced length of hospital stay was uniformly neutral across 3 studies, even at high doses (3 g four times daily).

Effective dose patterns: When effective, doses most commonly cluster around 1000 mg/day (or 1 g daily), especially for interleukin-6 reduction, CRPS prevention, and oxidative stress. For TNF-α, the range is 250–1000 mg/day. For lung function, 500 mg/day was used in the single beneficial RCT. Mortality and hospital stay studies often used higher doses (up to 3 g four times daily) but without consistent benefit.

Population insights: Most research focuses on clinical populations rather than healthy individuals. Surgical patients (cardiac, arthroplasty, extraction) appear in multiple outcomes (CRPS, pain, interleukin-6). Patients with type 2 diabetes show blood pressure benefits. Critically ill patients (sepsis, COVID-19) dominate mortality and hospital stay studies. Older women with sarcopenia and hemodialysis patients appear in inflammation outcomes. Generalizability to healthy adults is often unclear.

Notable caveats: Across all syntheses, evidence bases are small (3–5 studies per outcome), making conclusions preliminary. Publication bias is a recurring concern—null results may be underreported. Many studies use vitamin C in combination with other interventions (thiamine, vitamin E, hydrocortisone), making it difficult to isolate its specific effect. Several outcomes have studies that did not reach statistical significance, suggesting true effects may be smaller than observed. Dosing and forms are inconsistently reported, limiting dose-response conclusions.

Frequently asked

  • What is Vitamin C good for according to research?
    The strongest research supports vitamin C for reducing interleukin-6 levels (3 of 5 studies beneficial, moderate effect) and for reducing complex regional pain syndrome after knee surgery (3 of 3 studies beneficial, small effect). Moderate evidence also suggests benefits for systolic blood pressure reduction. Weaker evidence hints at possible effects on pain, oxidative stress, and tumor necrosis factor alpha, but results are mixed.
  • What dose of Vitamin C is typically used in studies?
    Doses around 1000 mg per day (or 1 g daily) are most common across outcomes with positive results, including interleukin-6 reduction, CRPS prevention, and oxidative stress. For lung function, one beneficial RCT used 500 mg/day. In mortality and hospital stay studies, higher doses up to 3 g four times daily were used but without consistent benefit.
  • Who benefits most from Vitamin C?
    Most evidence comes from clinical populations rather than healthy individuals. Surgical patients (cardiac surgery, knee arthroplasty) show benefits for CRPS, pain, and inflammation. Adults with type 2 diabetes appear to benefit for blood pressure. Critically ill patients with sepsis or COVID-19 were studied for mortality and hospital stay, but benefits were not consistently observed.
  • Are there caveats or limitations in the research on Vitamin C?
    Yes, several. All outcomes are based on small numbers of studies (3–5 each), so conclusions are preliminary. Publication bias is a concern—null results may be underreported. Many studies combined vitamin C with other interventions (e.g., thiamine, vitamin E, hydrocortisone), making it difficult to isolate its effect. Additionally, several studies did not reach statistical significance, suggesting true effects may be smaller than reported.
  • Does Vitamin C help with reducing mortality risk?
    Evidence is weak and inconsistent. Across 5 studies, only 1 (in COVID-19 patients) found a moderate beneficial effect, while 4 studies in sepsis populations found neutral effects. Study durations were very short (median 4 days), and vitamin C was often given with other treatments (hydrocortisone, thiamine), making it unclear if vitamin C alone is responsible for any benefit.
  • Does Vitamin C improve lung function?
    Evidence is mixed. Of 4 studies, only 1—a high-quality RCT in children of pregnant smokers at 500 mg/day—found a significant moderate benefit. Meta-analyses in adults with asthma or COPD found no significant effect. Overall, the evidence is low strength and does not support a consistent benefit for lung function in general populations.

Most-studied combinations with Vitamin C

most supplement research is combination research
Also studied with:N-Acetyl Cysteine (3), L-Carnitine (3), Blood Orange (3), Quercetin (2), Zinc (3), Selenium (2), Vitamin B1 (4), Vitamin B3 (2), Vitamin A (4), Vitamin D (6), Vitamin E (14)
  • Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $22.95
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • MultiONE

    By Bluebonnet Nutrition

    4.7 (108 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $46.00
    In
    iHerb
    $46.00
    In
    Vitacost
    $46.00
    In
    Vitamin Shoppe
    $-
    Out
  • CircuLegs with Horse Chestnut

    By Solaray

    4.7 (111 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $33.38
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • Cranberry

    By Swanson

    4.8 (831 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $9.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • Collagen 1,500 + C

    By Mason Natural

    4.7 (1.6K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $13.40
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • Regeneration

    By NaturesPlus

    4.8 (137 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $39.91
    In
    Vitacost
    $42.00
    In
    Vitamin Shoppe
    $-
    Out
Back to top